Inositol-derived molecules (sometimes referred to as inositol phosphoglycans) appear to act as secondary messengers in insulin pathways, helping cells respond more effectively to insulins signal.15 21 In human trials, MI supplementation has been associated with improvements in insulin sensitivity, fasting glucose, and postprandial glucose handling in certain populations including people with insulin resistance and pregnant individuals at risk of gestational diabetes.7 22 23 Meta-analyses suggest a reduction in gestational diabetes incidence when inositol is used preventively, though authors consistently note the need for larger, higher-quality randomized trials before firm clinical recommendations can be made.9 24 25 26 Ovarian function and hormone signaling In ovarian tissue, MI plays a role in follicle-stimulating hormone (FSH) signaling and oocyte maturation.27 28 DCI, meanwhile, appears more involved in insulin-mediated androgen production.29 Because these roles differ, some researchers propose that the balance between MI and DCI may matter, particularly in polycystic ovary syndrome (PCOS).30 Clinical trials in people with PCOS have reported improvements in ovulation frequency, menstrual regularity, and some metabolic markers with inositol supplementation.2 31 However, systematic reviews emphasize that many studies are small, heterogeneous, and of variable quality, and that more rigorous trials are needed before drawing strong conclusions.3 17 Body weight and cardiometabolic markers Beyond glucose control, inositol has been studied for broader metabolic effects

One key process is glutamate excitotoxicity, where a buildup of glutamate at the synapse due to reduced function of the transporter EAAT2 (also known as GLT-1) leads to overstimulation of N-methyl-D-aspartate (NMDA) receptors
At [R2 Medical Clinic](/), we offer physician-supervised peptide protocols for athletes and fitness enthusiasts in Denver
2021 An interactive 3D model rendered from the compound record rotate and explore its structure
[DOI] [PubMed] [Google Scholar] 308.Hejazi M.E., Modarresi-Ghazani F., Hamishehkar H., Mesgari-Abbasi M., Dousti S., Entezari-Maleki T
In tendon and ligament pathology, both peptides have shown remarkable efficacy in preclinical models of tissue repair